Pfizer PFE Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | $9.87B-8.6% | $10.79B+36.4% | $7.91B-1.9% | ||
| $6.59B-0.1% | $6.59B-1.6% | $6.7B-1.4% | $6.79B-1.5% | $6.89B-1.7% | ||
| $901M+12.8% | $799M+6.4% | $751M-8.9% | $824M-0.4% | $827M-5.7% | ||
| $12.57B+2.3% | $12.29B-10.1% | $13.66B-13.4% | $15.77B+12.7% | $13.99B+9.8% | ||
| $2.5B-4.9% | $2.63B-2.7% | $2.7B-1.8% | $2.75B-0.7% | $2.77B-4.8% | ||
| -$3.84B-184% | -$1.35B— | —— | —— | —— | ||
| -$8.53B+21.8% | -$10.9B+31.9% | -$16.01B+11.9% | -$18.17B-4.2% | -$17.44B-1.7% | ||
| —— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Pfizer generate?
- Pfizer (PFE) generated $12.6B in operating cash flow over the trailing twelve months.
- What is Pfizer's free cash flow?
- After $2.5B of capital expenditures, Pfizer's free cash flow was $12.5B over the trailing twelve months, up 26.6% year over year.
- Where does Pfizer's cash flow data come from?
- Every line is extracted from Pfizer's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
